Sensorion
ALSEN | PA
Overview
Corporate Details
- ISIN(s):
- FR0012596468 (+2 more)
- LEI:
- 969500P0W8XJ9CGZDP97
- Country:
- France
- Address:
- 375 RUE DU PROFESSEUR BLAYAC, 34080 MONTPELLIER
- Website:
- https://www.sensorion.com/en/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Sensorion’s mission is to offer innovative therapeutic solutions providing long-term improvements to people living with, or at risk of, inner ear disorders. Sensorion’s portfolio of solutions to unmet medical and social needs in inner ear disorders rests on three pillars – Restore, Treat, Prevent. Restore We aim to restore hearing by treating genetic diseases previously regarded as untreatable. Treat We aim to treat hearing disorders through innovative small molecule therapeutic solutions. Prevent We aim to prevent non-genetic hearing loss (e.g drug or surgery-related) through targeted therapeutic programs.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-13 07:30 |
Declaration of Voting Results & Voting Rights Announcements
Informations privilégiées / Autres communiqués
|
French | 133.2 KB | |
| 2025-05-13 07:30 |
Declaration of Voting Results & Voting Rights Announcements
Inside Information / Other news releases
|
English | 139.4 KB | |
| 2025-05-06 07:30 |
Regulatory News Service
Inside Information / Other news releases
|
English | 180.6 KB | |
| 2025-05-06 07:30 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 176.8 KB | |
| 2025-04-25 07:30 |
Regulatory News Service
Inside Information / Other news releases
|
English | 151.9 KB | |
| 2025-04-25 07:30 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 171.2 KB | |
| 2025-04-18 09:24 |
General Meeting Notice
Inside Information / Other news releases
|
English | 163.1 KB | |
| 2025-04-18 09:24 |
General Meeting Notice
Informations privilégiées / Autres communiqués
|
French | 137.5 KB | |
| 2025-04-16 07:30 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 165.8 KB | |
| 2025-04-16 07:30 |
Regulatory News Service
Inside Information / Other news releases
|
English | 170.0 KB | |
| 2025-04-02 07:30 |
Board/Management Change
Informations privilégiées / Autres communiqués
|
French | 180.6 KB | |
| 2025-04-02 07:30 |
Board/Management Change
Inside Information / Other news releases
|
English | 175.9 KB | |
| 2025-03-31 07:30 |
Regulatory News Service
Inside Information / Other news releases
|
English | 169.5 KB | |
| 2025-03-31 07:30 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 176.0 KB | |
| 2025-03-26 07:30 |
Regulatory News Service
Inside Information / Other news releases
|
English | 163.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-04-11 | N/A | Other | Other | 2,781,914 | 1,752,605.82 EUR |
| 2024-04-11 | N/A | Other | Other | 1,587,301 | 999,999.63 EUR |
| 2024-02-13 | N/A | Other | Other | 16,842,105 | 9,599,999.85 EUR |
| 2024-02-08 | N/A | Other | Other | 12,280,701 | 6,999,999.57 EUR |
| 2023-08-08 | N/A | Other | Other | 46,428,571 | 12,999,999.88 EUR |
| 2023-08-03 | N/A | Other | Other | 25,000,000 | 7,000,000.00 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |